Out of the suburbs: the rise of urban labs
Could empty office blocks and shopping centres provide much-needed space for growing companies?
The hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
The problem of scale-up in the UK
What’s the point of knowledge generation if we’re not creating high value jobs, asks Chris Kay
Polymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
Fears grow over the future of mRNA vaccine research in the US
Acceptable levels of (epi)genetic engineering
The value of good software extends beyond its cost
Improving propylene synthesis using light-activated catalysis could cut emissions
29 dead in explosions at two illegal fireworks factories in India
BioLab fined for fire and chemical plume at US plant
Highlights
Making genetically engineered food palatable
The next generation of genetically altered food is forging ahead, aiming to be attractive to consumers rather than producers. Katrina Megget finds out whether Crispr means crisper salads
The glyphosate debate
The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide’s presence in British farming and considers the possibility of a ban in the UK
Putting the F in pharma
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame the ninth element
On the trail of the male contraceptive pill
As multiple novel male contraception compounds enter clinical trials, is family planning about to undergo a second revolution? James Mitchell Crow reports
The promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery
Polymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
Fears grow over the future of mRNA vaccine research in the US
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad
Acceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
The value of good software extends beyond its cost
Whether third-party or built in-house, thoughtful design and implementation can improve workflows and make science more inclusive
Acceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
29 dead in explosions at two illegal fireworks factories in India
Incidents in Gujarat and West Bengal highlight minimal oversight of hazardous industry
BioLab fined for fire and chemical plume at US plant
‘Improperly stored’ pool chemicals reacted with water to release chlorine
Government reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
Making genetically engineered food palatable
The next generation of genetically altered food is forging ahead, aiming to be attractive to consumers rather than producers. Katrina Megget finds out whether Crispr means crisper salads
I can’t believe it’s not…
The analytical techniques revealing the true identity of what you spread on your bread
Improving propylene synthesis using light-activated catalysis could cut emissions
Single-atom photocatalyst makes propylene at milder temperatures
Generative AI pipeline creates promising antimicrobial peptides
AI model extrapolates beyond training data to predict diverse antimicrobial structures
Far more drugs could be taken orally by formulating them with silica nanoparticles
Many more medicines could be made water soluble making taking them easier for patients
Mapping metabolite disturbances by drugs
High-throughput metabolomic profiling gives insight into unpredictable drug effects
Metal–organic framework captures carbon dioxide at industrially relevant temperatures
Material could improve energy efficiency of capturing carbon from industy’s exhaust gases
Fluorspar to fluorine chemicals without going via hazardous hydrogen fluoride
Safer way to turn calcium fluoride mineral into valuable industrial materials
Banned pigments found in tattoo inks sold in the EU
Nine out of 10 green and blue inks analysed violate Reach regulations
Nanopore sequencing set to transform our understanding of proteins
Rapid sequencing technique can not only deal with proteins hundreds of amino acids long but can detect modifications
Government reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
Bayer ordered to pay more than $2 billion to US cancer victim
Jury decided glyphosate-based Roundup herbicide caused cancer, but company will appeal
The hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
Improving propylene synthesis using light-activated catalysis could cut emissions
Single-atom photocatalyst makes propylene at milder temperatures
The hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
The problem of scale-up in the UK
What’s the point of knowledge generation if we’re not creating high value jobs, asks Chris Kay
BioLab fined for fire and chemical plume at US plant
‘Improperly stored’ pool chemicals reacted with water to release chlorine
Government reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
Trump’s tariff stand-off
Piling cost and complexity to stretched global supply chains will hit industries hard
Trump’s new tariffs threaten the chemicals sector
Broad and high tariffs could mean severe job losses and supply chain disruption for chemistry-using industries
Dow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
Sanofi spins out its consumer healthcare business
US-based investment firm takes controlling stake in Opella, while France’s government moves to ensure the company remains in the country
Pass or fail: rapid polymer analysis with FTIR
Your guide to quick and reliable verification of polymers with the Lyza 7000 FTIR spectrometer
Illuminating progress: recent advances in photoredox catalysis
In this free download, shed some light on the latest developments in photoredox for drug development and materials science
Digital tools for deft materials development
Discover how Microsoft can help you turn years of lab work into days of computation
